Prestige Consumer Healthcare Inc.
PBH· NYSE
PBHPrestige Consumer Healthcare Inc.
Filed May 6, 2022 · 10-K · 36 days after period end · 0001295947-22-000015
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $266.94M | $237.76M | $251.24M | $241.03M |
| Net Income | $52.09M | $35.51M | $37.05M | -$139.27M |
| EPS Diluted | — | — | $0.73 | -$2.68 |
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2022 · filed May 6, 2022 · 36 d after period end
